➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
Colorcon
Baxter
Johnson and Johnson

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Litigation Details for ENCORE DERMATOLOGY INC. v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2020)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ENCORE DERMATOLOGY INC. v. GLENMARK PHARMACEUTICALS LIMITED
The small molecule drug covered by the patents cited in this case is   Get Started Free .

Details for ENCORE DERMATOLOGY INC. v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-03-05 1 Complaint Certification that the Claims of U.S. Patent Nos. 9,855,334, 9,956,231, and 10,064,875 are Invalid, Unenforceable…owns by assignment U.S. Patent No. 9,956,231 (the “’231 Patent”). The ’231 Patent was issued on May 1, … This is a civil action for patent infringement arising under the Patent Laws of the United States and…correct copy of the ’231 Patent is attached hereto as Exhibit C. The ’231 Patent expires on August 31, …or older. 24. The ’231 Patent, among other patents, is listed in the FDA’s Approved Drug External link to document
2020-12-21 55 Opinion owns U.S. Patent No. 9,956,231 (the “Patent”), which expires in 2030. (Compl. ¶ 17.) The Patent claims “…in a patent or the use of which is claimed in a patent before the expiration of such patent. 35 … has a patent for a topical pharmaceutical composition with the compound clobetasol. The patent also provides…any patents relate to the proposed drug. Id. Relevant here, the applicant may assert that a patent “will… drug claimed in a patent or the use of which is claimed in a patent . . . if the purpose External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Johnson and Johnson
Dow
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.